D. Alarkawi

Oral Bisphosphonate Use and All‐Cause Mortality in Patients With Moderate–Severe (Grade 3B‐5D) Chronic Kidney Disease: A Population‐Based Cohort Study

C. Cooper, A. Díez-Pérez, C. Tebé, 2020, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Impact of osteoporotic fracture type and subsequent fracture on mortality: the Tromsø Study

J. Eisman, J. Center, N. Emaus, 2019, Osteoporosis International.

Secular Changes in Postfracture Outcomes Over 2 Decades in Australia: A Time-Trend Comparison of Excess Postfracture Mortality in Two Birth Controls Over Two Decades.

J. Eisman, J. Center, Tuan V. Nguyen, 2016, The Journal of clinical endocrinology and metabolism.

Contribution of Lumbar Spine BMD to Fracture Risk in Individuals With T‐Score Discordance

J. Eisman, J. Center, Tuan V. Nguyen, 2016, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Predicting dissatisfaction following total hip arthroplasty using a Bayesian model averaging approach: Results from the Australian Arthroplasty Clinical Outcomes Registry National (ACORN)

S. Adie, R. Molnar, J. V. Van Meirhaeghe, 2021, ANZ journal of surgery.

The Challenges and Opportunities of Pharmacoepidemiology in Bone Diseases

J. Center, D. Prieto-Alhambra, M. S. Ali, 2018, JBMR plus.

Risk of Subsequent Fractures and Mortality in Elderly Women and Men with Fragility Fractures with and without Osteoporotic Bone Density: The Dubbo Osteoporosis Epidemiology Study

J. Eisman, J. Center, Tuan V. Nguyen, 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Accelerated bone loss and increased post-fracture mortality in elderly women and men

J. Eisman, J. Center, N. Nguyen, 2015, Osteoporosis International.

The association between multimorbidity and osteoporosis investigation and treatment in high-risk fracture patients in Australia: A prospective cohort study

F. Blyth, L. March, J. Center, 2023, PLoS medicine.

Anti-resorptive medication use is not associated with acute cardiovascular risk: An observational study: Anti-resorptive medication and cardiovascular risk.

F. Blyth, L. March, J. Center, 2022, The Journal of clinical endocrinology and metabolism.